BRIEF published on 06/10/2025 at 10:11, 9 months 8 days ago Edison Releases Report on BB Biotech Amidst Sector Challenges Investment Strategies Market Volatility Biotech Sector BB Biotech Long-term Outlook
PRESS RELEASE published on 06/10/2025 at 10:06, 9 months 8 days ago Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION) covering the recent challenges and opportunities in the biotech sector, including market volatility and long-term outlook Edison Market Volatility Biotech Sector BB Biotech Long-term Outlook
BRIEF published on 04/25/2025 at 07:05, 10 months 23 days ago BB Biotech AG Reports CHF 241 Million Net Loss for Q1 2025 Drug Development Net Loss Investment Portfolio Interim Report BB Biotech
BRIEF published on 04/25/2025 at 07:05, 10 months 23 days ago BB Biotech Q1 2025: Portfolio Adjustments Amid Volatile Market Market Volatility Investment Portfolio Biotech Sector BB Biotech FDA Approvals
PRESS RELEASE published on 04/25/2025 at 07:00, 10 months 23 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 10 months 23 days ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF published on 03/19/2025 at 17:50, 11 months 30 days ago BB Biotech AG Shareholders Approve Dividend and Re-Elect Board Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
PRESS RELEASE published on 03/19/2025 at 17:45, 11 months 30 days ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share Shareholders at BB Biotech AG’s AGM approve dividend of CHF 1.80 per share and all board proposals. Re-elected board members for another term Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/21/2025 at 07:05, 1 year ago BB Biotech AG Releases 2024 Annual Report Dividend Proposal Net Profit BB Biotech AG Biotechnology Sector 2024 Annual Report
BRIEF published on 02/21/2025 at 07:05, 1 year ago BB Biotech Navigates Biotech Sector's Early Recovery in 2024 Investment Strategy 2024 Financial Performance BB Biotech Regulatory Milestones Biotech Recovery
Published on 03/19/2026 at 01:05, 4 hours ago Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Published on 03/18/2026 at 23:45, 5 hours 20 minutes ago Orogen Royalties Announces Private Placement Update
Published on 03/18/2026 at 21:00, 8 hours 5 minutes ago PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie
Published on 03/18/2026 at 19:05, 10 hours ago Deposit Modeling at Thor Shows that the Proven Thor Epithermal Deposit is Flanked on Both Sides by a Much Larger Deposit
Published on 03/18/2026 at 18:10, 10 hours 55 minutes ago Silver X Mining Closes C$69M Brokered Private Placement of Secured Convertible Debentures
Published on 03/19/2026 at 03:50, 1 hour 15 minutes ago AWE2026 Signals the Future: A Defining Moment for the Age of AI
Published on 03/18/2026 at 22:00, 7 hours 5 minutes ago aap successfully completes MDR certification: All existing products approved according to MDR – market access in the EU and CE-relevant markets secured in the long term
Published on 03/18/2026 at 18:53, 10 hours 12 minutes ago EQS-Adhoc: Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025
Published on 03/18/2026 at 18:37, 10 hours 28 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/18/2026 at 19:41, 9 hours 24 minutes ago Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 11 hours 5 minutes ago Deezer achieves profitability in FY25 as strategy delivers tangible results
Published on 03/18/2026 at 17:45, 11 hours 20 minutes ago Infotel : 2025 full-year results. Launch of a new Infotel 2030 strategic plan. Revenue target of €500 million by 2030.
